Navigation Links
PharmSource Adds New Capabilities to the PharmSource ADVANTAGE Online Service
Date:4/22/2009

The PharmSource ADVANTAGE online service has added two new capabilities to its interactive database of more than 1,000 contract service providers.

Fairfax, Virginia (PRWEB) April 22, 2009 - PharmSource Information Services Inc., a respected provider of business intelligence on contract drug development and manufacture, is pleased to announce the addition of two new capabilities to its PharmSource ADVANTAGE online service. Currently, the company's interactive database provides information on more than 1,000 contract service providers. With the latest added features, subscribers will now be able to easily acquire an overall streamlined view of important market intelligence including contractor relationships and service provider revenue estimates.

Enhancements to the database of contract services providers include 1) the ability to search by client, and 2) the ability to compare companies by contract revenue range. The new search by client option enables subscribers to rapidly generate a comprehensive list of known contractor relationships for a particular bio/pharma company. With the addition of this feature, subscribers can search the database by the names of service providers, the names of clients, as well as particular capabilities among service providers.

The PharmSource ADVANTAGE database also contains a new option for the comparison of companies by contract revenue range. This new feature allows users to select and/or rank contract service providers by the size of their contract revenue. This enhances the ability to search and compare companies in the database by presenting a complete perspective of all companies within a certain contract revenue range.

About PharmSource Information Services, Inc.
PharmSource is a respected provider of business intelligence on contract drug development and manufacture. It serves as a premier information resource for both biotechnology/pharmaceutical sourcing executives and contract service providers.

Since 1996, PharmSource has provided organizations involved in contract pharma services with publications, databases, surveys and consulting services. Companies from around the world continually rely on PharmSource's deep industry expertise and analyses to help them make smarter strategic business decisions.

About PharmSource ADVANTAGE
The PharmSource ADVANTAGE online service is the industry's most respected outsourcing information web portal for serious consumers of information on contract drug development and manufacturing. This strategic resource allows subscribers to quickly identify and qualify service providers and provides industry insight and analysis through two regular publications - Bio/Pharmaceutical Outsourcing Report and Emerging Markets Outsourcing Report.

If you have questions regarding PharmSource Information Services Inc., please send an e-mail to info(at)pharmsource(dot)com or call 1-703-383-4903 (USA ET).

###

Read the full story at http://www.prweb.com/releases/2009/04/prweb2340864.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. PharmSource and BioProcess Technology Consultants Announce Publication of New Market Report: Cell Culture Manufacturing Capacity: Trends and Outlook through 2013
2. PharmSource President Moderates Videocast on Outsourcing to Asia at AAPS
3. PharmSource Introduces Proprietary Resource for Identifying New Business Opportunities in Bio/Pharma
4. SAFC Pharma Augments Assay Development Capabilities
5. Nikon Instruments A1 Confocal Laser Microscope Series With NIS-Elements C Software Delivers Fully Integrated Comprehensive Confocal Imaging Capabilities
6. Voler Expands Medical Device Design Capabilities
7. Avid Bioservices Expands Capabilities With Installation of Innovative Thermo Scientific HyClone Single-Use Bioreactor Systems
8. Will New Technological Advances Offer Fresh Capabilities for Commercialization and Enhance BTL Investments?
9. Autonomy Meridio Enables Extract Technology to Enhance Capabilities in Compliance With Manufacturing Regulations
10. PAREXEL Expands Global Clinical Logistics Capabilities
11. Kendle Expands Global Clinical Pharmacology Capabilities with Acquisition of DecisionLine Clinical Research Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2017)... ... June 22, 2017 , ... Ovation ... infertility as a disease, bringing new hope for prospective parents who are challenged ... meeting to back the World Health Organization’s designation in hopes of changing the ...
(Date:6/22/2017)... Lawrence, MA (PRWEB) , ... June 22, 2017 , ... ... completed ILVO validation. The AMPH test was determined to be appropriate as a screening ... for visual interpretation, on the Charm EZ system, and the Charm EZ Lite system. ...
(Date:6/20/2017)... ... June 20, 2017 , ... National ... well-versed leader with extensive assay development and biomarker expertise, as VP of Scientific ... Boston CRO specializing in bio-analytical assay development and sample testing services. The organization ...
(Date:6/19/2017)... ... June 19, 2017 , ... Tunnell Consulting has been solving the ... the biggest challenges faced by life sciences, biotech and pharmaceuticals companies today is in ... Kati Abraham , who is well known in the industry and brings significant high-level ...
Breaking Biology Technology:
(Date:4/11/2017)... NXT-ID, Inc. (NASDAQ:   NXTD ) ("NXT-ID" or ... independent Directors Mr. Robin D. Richards and Mr. ... the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive Officer said," ... and benefiting from their considerable expertise as we move forward ...
(Date:4/5/2017)... -- Today HYPR Corp. , leading innovator in ... the HYPR platform is officially FIDO® Certified . ... that empowers biometric authentication across Fortune 500 enterprises and ... 15 million users across the financial services industry, however ... suites and physical access represent a growing portion of ...
(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
Breaking Biology News(10 mins):